Correct diagnosis for indication in gastroesophageal reflux disease;Gastroösophageale refluxkrankheit. Welche diagnostik ist zur indikationsstellung notwendig?

Chirurg

Volumn 76, Issue 4, 2005, Pages 345-352

  Holscher A H ^a   Bollschweiler, E ^a   Gutschow, Ch ^a   Malfertheiner, P ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Diagnostics; Indication; Medical therapy; Reflux disease; Surgical therapy

Indexed keywords

BARIUM; PROTON PUMP INHIBITOR;

ANAMNESIS; BIOPSY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENDOSCOPY; EPITHELIUM; EROSION; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; LOWER ESOPHAGUS SPHINCTER; MANOMETRY; MEDICAL EXAMINATION; OUTCOMES RESEARCH; PH MEASUREMENT; POSTOPERATIVE PERIOD; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STENOSIS;

DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; ESOPHAGITIS, PEPTIC; EVIDENCE-BASED MEDICINE; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 20044362976     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-004-0955-0     Document Type: Review

References (68)

1. Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM (1999) Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc 50:23-26
2. Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med 72:93-100
3. Bartels F, Hahn HJ, Stolte M, Schmidt-Wilcke HA (2003) Zur Qualität der Diagnostik und zur Häufigkeit endoskopisch definierter Erkrankungen des oberen Gastrointestinaltraktes. Z Gastroenterol 41:311-318
4. Bechi P, Pucciani F, Baldini F et al. (1993) Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 38:1297-1306
5. Blom D, Peters JH, DeMeester TR, Crookes PF, Hagan JA, DeMeester SR, Bremner C (2000) Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication. J Gastrointest Surg 6:22-28
6. Blom D, Peters J, De MT, Crookes P, Hagan J, De MS, Bremner C (2002) Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication. J Gastrointest Surg 6:2228
7. Bollschweiler E (1991) Wertigkeit verschiedener diagnostischer Verfahren bei Refluxkrankheit - eine prospektive klinische Untersuchung. In: Fuchs KH, Hamelmann H (eds) Gastrointestinale Funktionsdiagnostik in der Chirurgie. Blackwell, Berlin, pp 75-85
8. Bollschweiler E, Feussner H, Hölscher AH, Siewert JR (1993) pH monitoring: the gold Standard in detection of gastrointestinal reflux disease? Dysphagia 8:118-121
9. Booth M, Stratford J, Dehn TC (2002) Preoperative esophageal body motility does not influence the outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease. Dis Esophagus 15:57-60
10. Bowrey DJ, Williams GT, Clark GW (2003) Histological changes in the oesophageal squamous mucosa: correlation with ambulatory 24 hour pH monitoring. J Clin Pathol 56:205-208
11. Bremner RM, Crookes PF, DeMeester TR, Peters JH, Stein HJ (1992) Concentration of refluxed acid and esophageal mucosal injury. Am J Surg 164:522-527
12. Campos GM, Peters JH, DeMeester TR et al. (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3:292-300
13. Connor M, Sharma P (2003) Chromoendoscopy and magnification endoscopy in Barrett's esophagus. Gastrointest Endosc Clin N Am 13:269-277
14. DeVault KR, Castell DO (1999) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 94:1434-1442
15. Faller G, Berndt R, Borchard F et al. (2003) Histopathologische Diagnostik der Barett-Schleimhaut und ihrer Neoplasien - Ergebnisse einer Konsensus-Konferenz der Arbeitsgemeinschaft "Gastroenterologische Pathologie" der Deutschen Gesellschaft für Pathologie am 22. September 2001 in Erlangen. Pathologe 24:9-14
16. Fass R, Mackel C, Sampliner RE (1994) 24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment. J Clin Gastroenterol 19:97-99
17. Fass R, Hell RW, Garewal HS, et al. (2001) Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 48:310-313
18. Fibbe C, Layer R Keller J, Strate U, Emmermann A, Zornig C (2001) Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology 121:5-14
19. Frantzides CT, Carlson MA, Madan AK, Stewart ET, Smith C (2003) Selective use of esophageal manometry and 24-Hour pH monitoring before laparoscopic fundoplication. J Am Coll Surg 197:358-354
20. Fuchs KH, DeMeester TR, Albertucci M (1987) Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. Surgery 102:575-580
21. Fuchs KH, Stein HJ, Thiede A (1997) Gastrointestinale Funktionsstörungen - Diagnose, Operationsindikation, Therapie. Springer, Berlin Heidelberg
22. Hölscher AH, Blum AL (2003) Chirurgische und medikamentöse Therapie der Gastroösophagealen Refluxerkrankung - Konsens einer pro und contra Diskussion. Z Gastroenterol 41:729-732
23. Hölscher AH, Bollschweiler E, Roesch W (2004) Ösophagus- Refluxerkrankung: Konservative oder operative Erkrankung? Dtsch Med Wochenschr 129:1-4
24. Hotz J, Madisch A, Classen M, Malfertheiner P, Rosch W (2000) Internationaler Konsens zur Reflux-krankheit der Speiseröhre. Dtsch Med Wochenschr 125:1308-1312
25. Jamieson JR, Stein HJ, DeMeester TR, et al. (1992) Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 87:1102-1111
26. Johnson DA, Fennerty MB (2004) Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 126:660-664
27. Johnsson F, Joelsson B (1988) Reproducibility of ambulatory oesophageal pH monitoring. Gut 29:886-889
28. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L (1998) One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 33:15-20
29. Johnsson F, Hatlebakk JG, Klintenberg AC et al. (2003) One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 38:354-359
30. Johnston BT, Troshinsky MB, Castell JA, Castell DO (1996) Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol 91:1181-1185
31. Juul-Hansen P, Rydning A (2003) Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice? Scand J Gastroenterol 38:1200-1203
32. Kahrilas PJ, Quigley EM (1996) Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 110:1982-1996
33. Katzka DA, Paoletti V, Leite L, Castell DO (1996) Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 91:2110-2113
34. Lord RV, Kaminski A, Oberg S et al. (2002) Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg 6:3-9; discussion 10
35. Luedtke P, Levine MS, Rubesin SE, et al. Radiologic diagnosis of benign esophageal strictures: a pattern approach. Radiographics 23:897-909
36. Madisch A, Kulich K, Malfertheiner P et al. (2003) Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol 41:1137-1143
37. Madsen E, Aksglaede K, Jacobsen NO, Funch-Jensen P, Thommesen P (2001) Gastro-oesophageal reflux demonstrated by radiography. A supplement to 24-h pH monitoring. Acta Radiol 42:521-525
38. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R (2003) Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 17:537-545
39. Martinez-Serna T, Tercero F, Filipi CJ, Dickason TJ, Watson P, Mittal SK, Tasset MR (1999) Symptom priority ranking in the care of gastroesophageal reflux: a review of 1,850 cases. Dig Dis 17:219-224
40. Masclee AA, de-Best AC, de-Graaf R, Cluysenaer OJ, Jansen JB (1990) Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol 25:225-230
41. Miguel PR, Moreira-da-Rosa AL, Reusch M, Aguzzoli M (1999) Esophageal manometry and 24-hour pH monitoring to evaluate laparoscopic Lind fundoplication in gastroesophageal reflux disease. 3:197-201
42. Mueller J, Werner M, Stolte M (2004) Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg 28:148-154
43. Murphy DW, Yuan Y, Castell DO (1989) Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci 34:649-656
44. Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S (1997) Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 40:710-715
45. Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S (2000) Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci 45:217-224
46. Numans ME, de-Wit NJ. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastro-oesophageal reflux disease questionnaire. Aliment Pharmacol Ther 17:1049-1055
47. O'Boyle O, Watson DI, DeBeaux AC, Jamieson GG (2002) Preoperative prediction of long-term outcome following laparoscopic fundoplication. 72:471-475
48. Ott DJ, McManus CM, Ledbetter MS, Chen MY, Gelfand DW (1997) Heartburn correlated to 24-hour pH monitoring and radiographic examination of the esophagus. Am J Gastroenterol 92:1827-1830
49. Pan JJ, Levine MS, Redfern RO, Rubesin SE, Laufer I, Katzka DA (2003) Gastroesophageal reflux: comparison of barium studies with 24-h pH monitoring. Eur J Radiol 47:149-153
50. Pare P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R (2003) Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol 17:307-312
51. Patti MG, Diener U, Tamburini A, Molena D, Way LW (2001) Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 46:597-602
52. Pehl C, Keller J, Merio R, Stacher G (2003) 24-Stunden-Ösophagus-pH- Metrie. Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität und der Arbeitsgruppe für gastrointestinale Funktionsstörungen und Funktionsdiagnostik der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie. Z Gastroenterol 41:545-556
53. Rydberg L, Ruth M, Lundell L (1997) Does oesophageal motor function improve with time after successful antireflux surgery? Results of a prospective, randomised clinical study. Gut 41:82-86
54. Salminen JT, Tuominen JA, Ramo OJ, et al. (1999) Oesophageal acid exposure: higher in Barrett's oesophagus than in reflux oesophagitis. Ann Med 31:46-50
55. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC et al. (1997) Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 92:1997-2000
56. Shaw MJ, Talley NJ, Beebe TJ et al. (2001) Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 96:52-57
57. Shay SS, Johnson LF, Richter JE (2003) Acid rereflux: a review, emphasizing detection by impedance, manometry, and scintigraphy, and the impact on acid clearing pathophysiology as well as interpreting the pH record. Dig Dis Sci 48:1-9
58. Siewert JR, Ottenjann R, Heilmann K, Neiss A, Dopfer H (1986) Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I: Epidemiology and results of acute therapy. Z Gastroenterol 24:381-395
59. Siewert JR, Harder F, Rothmund M (2002) Gastroenterologische Chirurgie. Springer, Berlin Heidelberg New York
60. Stolte M, Vieth M (2002) Barrett-Metaplasie: Wie gefährlich ist sie wirklich? Z Gastroenterol 40 [Suppl] 2:5-8
61. Streets CG, DeMeester TR (2003) Ambulatory 24-hour esophageal pH monitoring: why, when, and what to do. J Clin Gastroenterol 37:14-22
62. Tefera L, Fein M, Ritter MP et al. (1997) Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Am Surg 63:933-936
63. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO (2001) Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120:1599-1606
64. Vieth M, Stolte M (2000) Kann man eine endoskopisch negative Refluxkrankheit histologisch diagnostizieren? Z Gastroenterol 38:817-818
65. Vieth M, Haringsma J, Delarive J, Wiesel PH, Tam W, Dent J, Tytgat GN, Stolte M, Lundell L (2001) Red streaks in the oesophagus in patients with reflux disease: is there a histomorphological correlate? Scand J Gastroenterol 36:1123-1127
66. Vieth M, Seitz G (2001) 50 Jahre Barrett-Ösophagus. Aktuelle diagnostische Möglichkeiten in der Pathologie. Pathologe 22:62-71
67. Wakelin DE, Al-Mutawa T, Wendel C, Green C, Garewal HS, Fass R (2003) A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 58:350-355
68. Zaninotto G, Portale G, Parenti A et al. (2002) Role of acid and bile reflux in development of specialised intestinal metaplasia in distal oesophagus. 34:251-257